D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 81 Citations 20,667 300 World Ranking 11527 National Ranking 6038
Biology and Biochemistry D-index 84 Citations 22,739 318 World Ranking 2128 National Ranking 1183

Overview

What is he best known for?

The fields of study he is best known for:

  • Enzyme
  • Gene
  • Bacteria

His primary areas of study are Biochemistry, Bile acid, Internal medicine, Endocrinology and Cholesterol 7 alpha-hydroxylase. His Bile acid study frequently links to other fields, such as Microbial metabolism. Phillip B. Hylemon combines subjects such as Probiotic and Feces with his study of Internal medicine.

Phillip B. Hylemon interconnects Nonalcoholic fatty liver disease, Steatohepatitis, Phosphorylation and Biliary tract in the investigation of issues within Endocrinology. His Cholesterol 7 alpha-hydroxylase research includes elements of Reverse cholesterol transport and Hepatocyte. His research integrates issues of Microbiology and Bacteria in his study of CYP8B1.

His most cited work include:

  • Bile salt biotransformations by human intestinal bacteria. (1432 citations)
  • Bile Acids and the Gut Microbiome (511 citations)
  • Altered profile of human gut microbiome is associated with cirrhosis and its complications (460 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Biochemistry, Internal medicine, Bile acid, Endocrinology and Cholesterol. Biochemistry is closely attributed to Molecular biology in his research. His Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology, Feces and Rifaximin.

His research investigates the connection with Bile acid and areas like Bacteria which intersect with concerns in Microbiology. His studies deal with areas such as Reductase and Hepatocyte as well as Cholesterol. His study focuses on the intersection of Cirrhosis and fields such as Gut flora with connections in the field of Microbiome.

He most often published in these fields:

  • Biochemistry (43.16%)
  • Internal medicine (38.60%)
  • Bile acid (37.08%)

What were the highlights of his more recent work (between 2016-2021)?

  • Internal medicine (38.60%)
  • Cirrhosis (13.68%)
  • Gastroenterology (12.77%)

In recent papers he was focusing on the following fields of study:

The scientist’s investigation covers issues in Internal medicine, Cirrhosis, Gastroenterology, Bile acid and Endocrinology. His work carried out in the field of Cirrhosis brings together such families of science as Feces, Antibiotics, Cohort study and Dysbiosis. His Gastroenterology research includes themes of Gut flora, Rifaximin and Itching.

His Bile acid study is associated with Biochemistry. In his work, Bile acid metabolism, Carbon dioxide and Symbiosis is strongly intertwined with Acetogenesis, which is a subfield of Biochemistry. His Endocrinology research incorporates elements of Sulfation and Farnesoid X receptor.

Between 2016 and 2021, his most popular works were:

  • The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids (130 citations)
  • The role of sphingosine 1-phosphate receptor 2 in bile-acid-induced cholangiocyte proliferation and cholestasis-induced liver injury in mice. (75 citations)
  • Cholangiocyte-derived exosomal long noncoding RNA H19 promotes cholestatic liver injury in mouse and humans. (59 citations)

In his most recent research, the most cited papers focused on:

  • Enzyme
  • Gene
  • Bacteria

His primary areas of investigation include Internal medicine, Bile acid, Cirrhosis, Liver injury and Gastroenterology. His work in Internal medicine tackles topics such as Endocrinology which are related to areas like Alkaline phosphatase, Nuclear receptor, Obeticholic acid, Triptolide and Farnesoid X receptor. To a larger extent, Phillip B. Hylemon studies Biochemistry with the aim of understanding Bile acid.

Phillip B. Hylemon interconnects Symbiosis and Acetogenesis in the investigation of issues within Biochemistry. His Cirrhosis research is multidisciplinary, incorporating elements of Steatosis, Antibiotics, Steatohepatitis, Type 2 diabetes and Dysbiosis. The various areas that Phillip B. Hylemon examines in his Liver injury study include Cancer research, Primary sclerosing cholangitis and Cholestasis.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Bile salt biotransformations by human intestinal bacteria.

Jason M. Ridlon;Dae Joong Kang;Phillip B. Hylemon.
Journal of Lipid Research (2006)

2260 Citations

Bile Acids and the Gut Microbiome

Jason M. Ridlon;Dae Joong Kang;Phillip B. Hylemon;Jasmohan S. Bajaj.
Current Opinion in Gastroenterology (2014)

895 Citations

Altered profile of human gut microbiome is associated with cirrhosis and its complications

Jasmohan S. Bajaj;Douglas M. Heuman;Phillip B. Hylemon;Arun J. Sanyal.
Journal of Hepatology (2014)

796 Citations

Bile acids as regulatory molecules.

Phillip B. Hylemon;Huiping Zhou;William M. Pandak;Shunlin Ren.
Journal of Lipid Research (2009)

600 Citations

Modulation of the Fecal Bile Acid Profile by Gut Microbiota in Cirrhosis

Genta Kakiyama;William M. Pandak;Patrick M. Gillevet;Phillip B. Hylemon.
Journal of Hepatology (2013)

594 Citations

Consequences of bile salt biotransformations by intestinal bacteria

Jason M. Ridlon;Spencer C. Harris;Shiva Bhowmik;Dae Joong Kang.
Gut microbes (2016)

562 Citations

Linkage of gut microbiome with cognition in hepatic encephalopathy

Jasmohan Singh Bajaj;Jason M. Ridlon;Phillip B. Hylemon;Leroy R Thacker.
American Journal of Physiology-gastrointestinal and Liver Physiology (2012)

519 Citations

Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation

Jasmohan Singh Bajaj;Phillip B. Hylemon;Jason M. Ridlon;Douglas M. Heuman.
American Journal of Physiology-gastrointestinal and Liver Physiology (2012)

474 Citations

Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy.

Jasmohan S. Bajaj;Douglas M. Heuman;Arun J. Sanyal;Phillip B. Hylemon.
PLOS ONE (2013)

398 Citations

Down-regulation of Cholesterol 7α-Hydroxylase (CYP7A1) Gene Expression by Bile Acids in Primary Rat Hepatocytes Is Mediated by the c-Jun N-terminal Kinase Pathway

Seema Gupta;R. Todd Stravitz;Paul Dent;Phillip B. Hylemon.
Journal of Biological Chemistry (2001)

385 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Phillip B. Hylemon

Jasmohan S. Bajaj

Jasmohan S. Bajaj

Virginia Commonwealth University

Publications: 84

John Y. L. Chiang

John Y. L. Chiang

Northeast Ohio Medical University

Publications: 71

Wei Jia

Wei Jia

Hong Kong Baptist University

Publications: 67

Bernd Schnabl

Bernd Schnabl

University of California, San Diego

Publications: 66

Michael Trauner

Michael Trauner

Medical University of Vienna

Publications: 44

Alan F. Hofmann

Alan F. Hofmann

University of California, San Diego

Publications: 40

Ingemar Björkhem

Ingemar Björkhem

Karolinska University Hospital

Publications: 39

Gianfranco Alpini

Gianfranco Alpini

Veterans Health Administration

Publications: 31

Willem M. de Vos

Willem M. de Vos

Wageningen University & Research

Publications: 31

Frank J. Gonzalez

Frank J. Gonzalez

National Institutes of Health

Publications: 31

Lanjuan Li

Lanjuan Li

Zhejiang University

Publications: 30

Bart Staels

Bart Staels

University of Lille

Publications: 30

Douglas M. Heuman

Douglas M. Heuman

Virginia Commonwealth University

Publications: 28

Fredrik Bäckhed

Fredrik Bäckhed

University of Gothenburg

Publications: 27

Julian R. Marchesi

Julian R. Marchesi

Imperial College London

Publications: 27

Folkert Kuipers

Folkert Kuipers

University Medical Center Groningen

Publications: 27

Trending Scientists

Osmar R. Zaïane

Osmar R. Zaïane

University of Alberta

Peter Šemrl

Peter Šemrl

University of Ljubljana

Kazuya Kikuchi

Kazuya Kikuchi

Osaka University

John Mundy

John Mundy

University of Copenhagen

Kelvin S.-H. Peh

Kelvin S.-H. Peh

University of Southampton

A. De Vries

A. De Vries

University of Florida

Kairbaan Hodivala-Dilke

Kairbaan Hodivala-Dilke

Queen Mary University of London

Mehmet Ozturk

Mehmet Ozturk

Izmir Biomedicine and Genome Center

Shin-ichi Teshima

Shin-ichi Teshima

Kagoshima University

Martine Cador

Martine Cador

University of Bordeaux

Achim Hoerauf

Achim Hoerauf

University of Bonn

Deborah Gorman-Smith

Deborah Gorman-Smith

University of Chicago

Ingrid Melle

Ingrid Melle

University of Oslo

Jose Lopez-Sendon

Jose Lopez-Sendon

Hospital Universitario La Paz

Christopher D. Byrne

Christopher D. Byrne

National Institute for Health Research

Adam J. Burgasser

Adam J. Burgasser

University of California, San Diego

Something went wrong. Please try again later.